The structure of Lissodendrins B and the third-generation ABCB1 inhibitors OC144-093 have similar ‘Y’-type skeleton structural characteristics and may have ABCB1 inhibitory activity to reverse tumor MDR (Figure 1). This evidence concerns the gene ABCB1 and neoplasm.